↗️ Wayfair (W), RH (RH), Williams-Sonoma (WSM): President Trump delayed by a year tariff increases on upholstered furniture, kitchen cabinets and vanities. Shares in furniture sellers rallied Friday. ↘️ Tesla (TSLA): The car maker reported an 8. Go to Source
Category: Suppliers
These Stocks Moved the Most Today: Tesla, Baidu, Western Digital, Micron, RH, Vertiv, Sable Offshore, AppLovin, and More
Tesla falls after the electric-vehicle maker’s disappointing fourth-quarter delivery numbers, while Baidu jumps as it plans to list its AI chip unit. Go to Source
Elon Musk promised a ‘major rebound’ for Tesla in 2025. Instead it fell behind its biggest rival from China
Tesla lost its crown as the world’s bestselling electric vehicle maker on Friday as a customer revolt over Elon Musk’s right-wing politics, expiring U.S. tax breaks for buyers and stiff overseas competition pushed sales down for a second year in a row. Tesla said that it delivered 1.64 million vehicles in 2025, down 9% from a… Continue reading Elon Musk promised a ‘major rebound’ for Tesla in 2025. Instead it fell behind its biggest rival from China
Tesla Fails to Step Over Wall Street’s Already Low Bar
Analysts anticipated weak fourth-quarter vehicle deliveries from Tesla (NASDAQ:TSLA), with estimates indicating a 15% decline as consumer demand dried up due to the expiration of federal electric vehicle (EV) tax credits. Having pulled sales forward into the company’s third quarter, which saw record deliveries, even CEO Elon Musk admitted Tesla was facing a few difficult… Continue reading Tesla Fails to Step Over Wall Street’s Already Low Bar
Tesla feels pressure from BYD in EV sales race
BYD said its sales of battery‑powered cars surged almost 28% in 2025 to more than 2.25 million, firmly outpacing Tesla’s projected 1.6–1.65 million deliveries for the year. CNBC reported that BYD disclosed 2.26 million battery‑electric sales, while analyst estimates compiled by the network … Go to Source
Aptiv to Release Fourth Quarter 2025 Financial Results
Go to Source
Michelin announces two acquisition projects, aiming at reinforcing its Polymer Composite Solutions business
Clermont-Ferrand, January 2, 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin announces two projects of acquisition,aiming at reinforcing its Polymer Composite Solutions business Michelin accelerates growth with the acquisitions of Cooley Group and Tex Tech… Continue reading Michelin announces two acquisition projects, aiming at reinforcing its Polymer Composite Solutions business
Michelin annonce deux projets d’acquisition, visant à renforcer son activité Polymer Composite Solutions
Clermont-Ferrand, 2 janvier 2026 COMPAGNIE GÉNÉRALE DES ÉTABLISSEMENTS MICHELIN Michelin annonce deux projets d’acquisition,visant à renforcer son activité Polymer Composite Solutions Michelin accélère sa croissance avec l’acquisition de Cooley Group et de Tex Tech… Continue reading Michelin annonce deux projets d’acquisition, visant à renforcer son activité Polymer Composite Solutions
Dana Incorporated Completes Sale of Off-Highway Business
MAUMEE, Ohio, Jan. 2, 2026 /PRNewswire/ — Dana Incorporated (NYSE: DAN) today announced the completion of its previously disclosed sale of the Off-Highway business to Allison Transmission Holdings, Inc. (NYSE: ALSN; “Allison”) for $2.7 billion. Dana Incorporated logo. (PRNewsFoto/Dana Incorporated) The transaction, valued at 7.5 times the Off-Highway business’s expected 2025 adjusted EBITDA, represents a significant… Continue reading Dana Incorporated Completes Sale of Off-Highway Business
Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics
Chicago, IL – January 2, 2026 – Stocks in this week’s article are The AES Corporation AES, BorgWarner BWA, Enersys ENS, PG&E Corporation PCG and Keros Therapeutics KROS. 5 Low Price-to-Book Stocks to Buy as 2025 Comes to a Close Value investors have, over the years, preferred the price-to-earnings ratio or P/E, as a means… Continue reading Zacks.com featured highlights include AES, BorgWarner, Enersys, PG&E and Keros Therapeutics